These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22081338)

  • 1. Reduction of preanalytical variability in specimen procurement for molecular profiling.
    Espina V; Mueller C
    Methods Mol Biol; 2012; 823():49-57. PubMed ID: 22081338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability.
    Espina V; Mueller C; Edmiston K; Sciro M; Petricoin EF; Liotta LA
    Proteomics Clin Appl; 2009 Aug; 3(8):874-882. PubMed ID: 20871745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
    Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
    J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoprotein stability in clinical tissue and its relevance for reverse phase protein microarray technology.
    Espina V; Mueller C; Liotta LA
    Methods Mol Biol; 2011; 785():23-43. PubMed ID: 21901591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tools to assess tissue quality.
    Neumeister VM
    Clin Biochem; 2014 Mar; 47(4-5):280-7. PubMed ID: 24565988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer predictive factor testing: the challenges and importance of standardizing tissue handling.
    Hicks DG; Kushner L; McCarthy K
    J Natl Cancer Inst Monogr; 2011; 2011(42):43-5. PubMed ID: 21672896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A portrait of tissue phosphoprotein stability in the clinical tissue procurement process.
    Espina V; Edmiston KH; Heiby M; Pierobon M; Sciro M; Merritt B; Banks S; Deng J; VanMeter AJ; Geho DH; Pastore L; Sennesh J; Petricoin EF; Liotta LA
    Mol Cell Proteomics; 2008 Oct; 7(10):1998-2018. PubMed ID: 18667411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research.
    Hicks DG; Boyce BF
    Biotech Histochem; 2012 Jan; 87(1):14-7. PubMed ID: 21732745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manual exfoliation of fresh tissue obviates the need for frozen sections for molecular profiling.
    Mojica WD; Rapkiewicz AV; Liotta LA; Espina V
    Cancer; 2005 Dec; 105(6):483-91. PubMed ID: 16015639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistency of a two clinical site sample collection: a proteomics study.
    Wiesner C; Hannum C; Reckamp K; Figlin R; Dubridge R; Roy SM; Lin S; Becker CH; Jones T; Hiller J; Cheville JC; Wilson K
    Proteomics Clin Appl; 2010 Sep; 4(8-9):726-38. PubMed ID: 21137090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-speciating Campylobacter jejuni by proteomic analysis of its protein biomarkers and their post-translational modifications.
    Fagerquist CK; Bates AH; Heath S; King BC; Garbus BR; Harden LA; Miller WG
    J Proteome Res; 2006 Oct; 5(10):2527-38. PubMed ID: 17022624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical points in urinary proteomics.
    Thongboonkerd V
    J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Standard" protocol for evaluating the impact of preanalytical variables on peptidic and proteic analytes and standard coding of preanalytical procedures].
    Betsou F; Beaudeux JL; Berthelaix A; Borg J; Dupuy A; Lizard G; Peoc'h K; Quillard M; Lehmann S
    Ann Biol Clin (Paris); 2009; 67(6):641-9. PubMed ID: 19939767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation.
    Jackson DH; Banks RE
    Proteomics Clin Appl; 2010 Mar; 4(3):250-70. PubMed ID: 21137047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industrialized MS-based proteomics in the search for circulating biomarkers.
    Migneault I; Hunter JM
    Bioanalysis; 2009 Sep; 1(6):1149-63. PubMed ID: 21083081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transportation and delay in processing on the stability of nutritional and metabolic biomarkers.
    Murphy JM; Browne RW; Hill L; Bolelli GF; Abagnato C; Berrino F; Freudenheim J; Trevisan M; Muti P
    Nutr Cancer; 2000; 37(2):155-60. PubMed ID: 11142087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of preanalytical variables on myeloperoxidase levels.
    Wendland AE; Camargo JL; Polanczyk CA
    Clin Chim Acta; 2010 Nov; 411(21-22):1650-5. PubMed ID: 20599864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards.
    Poste G
    Trends Mol Med; 2012 Dec; 18(12):717-22. PubMed ID: 23122852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for plasma proteomic profiling of cancers.
    Omenn GS
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.
    Srivastava G; Singh K; Tiwari MN; Singh MP
    Expert Rev Proteomics; 2010 Feb; 7(1):127-39. PubMed ID: 20121482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.